{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T06:20:47Z","timestamp":1780726847518,"version":"3.54.1"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.ejpb.2016.11.029","type":"journal-article","created":{"date-parts":[[2016,11,27]],"date-time":"2016-11-27T06:46:06Z","timestamp":1480229166000},"page":"138-142","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Complexation hydrogels as potential carriers in oral vaccine delivery systems"],"prefix":"10.1016","volume":"112","author":[{"given":"Mia","family":"Yoshida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriyasu","family":"Kamei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiya","family":"Muto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Kunisawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kozo","family":"Takayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas A.","family":"Peppas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariko","family":"Takeda-Morishita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2016.11.029_b0005","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1600-065X.1999.tb01339.x","article-title":"Mucosal immunity and tolerance: relevance to vaccine development","volume":"170","author":"Czerkinsky","year":"1999","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.ejpb.2016.11.029_b0010","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/nri1777","article-title":"Mucosal vaccines: the promise and the challenge","volume":"6","author":"Neutra","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ejpb.2016.11.029_b0015","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.addr.2015.03.007","article-title":"Delivery strategies to enhance oral vaccination against enteric infections","volume":"91","author":"Davitt","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2016.11.029_b0020","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jconrel.2004.03.008","article-title":"Mucosal insulin delivery systems based on complexation polymer hydrogels: effect of particle size on insulin enteral absorption","volume":"97","author":"Morishita","year":"2004","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2016.11.029_b0025","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.jconrel.2006.03.005","article-title":"Characterization of insulin protection properties of complexation hydrogels in gastric and intestinal enzyme fluids","volume":"112","author":"Yamagata","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2016.11.029_b0030","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/jps.20566","article-title":"Gastrointestinal transit and mucoadhesive characteristics of complexation hydrogels in rats","volume":"95","author":"Goto","year":"2006","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2016.11.029_b0035","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jconrel.2008.11.014","article-title":"Complexation hydrogels for intestinal delivery of interferon beta and calcitonin","volume":"134","author":"Kamei","year":"2009","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2016.11.029_b0040","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0168-3659(02)00019-6","article-title":"Elucidation of the mechanism of incorporation of insulin in controlled release systems based on complexation polymers","volume":"81","author":"Morishita","year":"2002","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2016.11.029_b0045","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1021\/bm500588x","article-title":"Surface-modified P(HEMA-co-MAA) nanogel carriers for oral vaccine delivery: design, characterization, and in vitro targeting evaluation","volume":"15","author":"Duran-Lobato","year":"2014","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.ejpb.2016.11.029_b0050","unstructured":"M. Dur\u00e1n-Lobato, B. Carrillo-Conde, Y. Khairandish, N.A. Peppas, pH-responsive mannan-modified P(HEMA-co-MAA) Nano- hydrogel Carriers for Oral Vaccine Delivery, Proceed. PBP World Meeting, 9, 2014."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641116308724?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641116308724?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T10:23:21Z","timestamp":1536229401000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641116308724"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":10,"alternative-id":["S0939641116308724"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2016.11.029","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Complexation hydrogels as potential carriers in oral vaccine delivery systems","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2016.11.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}